Mark Paris

1.3k total citations
21 papers, 968 citations indexed

About

Mark Paris is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Mark Paris has authored 21 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Genetics. Recurrent topics in Mark Paris's work include Axon Guidance and Neuronal Signaling (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and NF-κB Signaling Pathways (3 papers). Mark Paris is often cited by papers focused on Axon Guidance and Neuronal Signaling (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and NF-κB Signaling Pathways (3 papers). Mark Paris collaborates with scholars based in United States, Peru and Canada. Mark Paris's co-authors include Edward M. Schwarz, Regis J. O’Keefe, Hicham Drissi, Yufeng Dong, Shonna A. Moodie, Alan Wolfman, Ernest Smith, Maurice Zauderer, Walter Kölch and Alan S. Jonason and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Mark Paris

21 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Paris United States 14 561 200 115 114 102 21 968
James C. Geoghegan United States 22 1.3k 2.3× 251 1.3× 102 0.9× 66 0.6× 81 0.8× 27 1.7k
E. Dreher Switzerland 20 302 0.5× 213 1.1× 200 1.7× 150 1.3× 46 0.5× 63 1.2k
Saixia Ying United States 13 619 1.1× 124 0.6× 105 0.9× 27 0.2× 159 1.6× 27 949
Tone Berge Norway 17 474 0.8× 137 0.7× 268 2.3× 65 0.6× 122 1.2× 34 832
Takehiko Koji Japan 17 354 0.6× 91 0.5× 128 1.1× 42 0.4× 66 0.6× 42 821
Sachiko Kubo Japan 11 359 0.6× 70 0.3× 239 2.1× 92 0.8× 44 0.4× 15 787
Jose G Ruiz de Morales Spain 14 291 0.5× 208 1.0× 142 1.2× 100 0.9× 40 0.4× 24 1.2k
David Y. Chin Australia 14 473 0.8× 250 1.3× 98 0.9× 41 0.4× 140 1.4× 26 866
Karin Wagner Austria 17 355 0.6× 123 0.6× 174 1.5× 36 0.3× 65 0.6× 31 815
Jui‐Lan Su United States 13 419 0.7× 125 0.6× 86 0.7× 26 0.2× 95 0.9× 21 842

Countries citing papers authored by Mark Paris

Since Specialization
Citations

This map shows the geographic impact of Mark Paris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Paris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Paris more than expected).

Fields of papers citing papers by Mark Paris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Paris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Paris. The network helps show where Mark Paris may publish in the future.

Co-authorship network of co-authors of Mark Paris

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Paris. A scholar is included among the top collaborators of Mark Paris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Paris. Mark Paris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Elizabeth E., Alan S. Jonason, Holm Bußler, et al.. (2015). Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunology Research. 3(6). 689–701. 88 indexed citations
2.
Fisher, Terrence L., Christine Reilly, Laurie A. Winter, et al.. (2015). Generation and preclinical characterization of an antibody specific for SEMA4D. mAbs. 8(1). 150–162. 36 indexed citations
3.
Klimatcheva, Ekaterina, Christine Reilly, Sebold Torno, et al.. (2015). CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunology. 16(1). 6–6. 94 indexed citations
4.
Evans, Elizabeth E., Mark Paris, Ernest Smith, & Maurice Zauderer. (2015). Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D. OncoImmunology. 4(12). e1054599–e1054599. 14 indexed citations
5.
Evans, Elizabeth E., Siwen Hu‐Lieskovan, Holm Bußler, et al.. (2015). Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations
6.
Evans, Elizabeth E., Alan S. Jonason, Mark Paris, et al.. (2013). Abstract 1245: Reduction of tumor growth and metastasis by a humanized IgG4 monoclonal antibody to SEMA4D (VX15/2503).. Cancer Research. 73(8_Supplement). 1245–1245. 1 indexed citations
7.
Vilchez, Gustavo, Liset Olarte, Carlos Carrillo, et al.. (2009). Brucellar uveitis: intraocular fluids and biopsy studies. International Journal of Infectious Diseases. 13(5). e206–e211. 12 indexed citations
8.
Olarte, Liset, Gustavo Vilchez, Larissa Otero, et al.. (2008). Ocular Manifestations Associated with Brucellosis: A 26‐Year Experience in Peru. Clinical Infectious Diseases. 46(9). 1338–1345. 40 indexed citations
9.
Polen, Hyla H., et al.. (2008). Ability of online drug databases to assist in clinical decision-making with infectious disease therapies. BMC Infectious Diseases. 8(1). 153–153. 29 indexed citations
10.
Soung, Do Y., Yoon Soo Chang, Motomi Enomoto‐Iwamoto, et al.. (2007). Transforming Growth Factor-β and Wnt Signals Regulate Chondrocyte Differentiation through Twist1 in a Stage-Specific Manner. Molecular Endocrinology. 21(11). 2805–2820. 52 indexed citations
11.
Evans, Elizabeth E., Alan S. Jonason, Mark Paris, et al.. (2006). C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Molecular Cancer Therapeutics. 5(11). 2919–2930. 43 indexed citations
12.
Dong, Yufeng, et al.. (2006). Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene. 372. 62–70. 277 indexed citations
13.
Paris, Mark, Eduardo Gotuzzo, Javier Aramburu, et al.. (2001). Motorcycle Taxi Drivers and Sexually Transmitted Infections in a Peruvian Amazon City. Sexually Transmitted Diseases. 28(1). 11–13. 11 indexed citations
14.
Paris, Mark & Bryan Williams. (2000). Characterization of a 500-kb Contig Spanning the Region between c-Ha-Ras and MUC2 on Chromosome 11p15.5. Genomics. 69(2). 196–202. 11 indexed citations
15.
Paris, Mark, Eduardo Gotuzzo, Javier Aramburu, et al.. (1999). Prevalence of Gonococcal and Chlamydial Infections in Commercial Sex Workers in a Peruvian Amazon City. Sexually Transmitted Diseases. 26(2). 103–107. 26 indexed citations
16.
Karnik, Pratima, Ping Chen, Mark Paris, Herman Yeger, & Bryan R.G. Williams. (1998). Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions. Oncogene. 17(2). 237–240. 37 indexed citations
17.
Plummer, Sarah J., et al.. (1997). Four regions of allelic imbalance on 17q12‐qter associated with high‐grade breast tumors. Genes Chromosomes and Cancer. 20(4). 354–362. 6 indexed citations
18.
Moodie, Shonna A., et al.. (1995). Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.. PubMed. 11(3). 447–54. 59 indexed citations
19.
Moodie, Shonna A., Mark Paris, Walter Kölch, & Alan Wolfman. (1994). Association of MEK1 with p21 ras GMPPNP Is Dependent on B-Raf. Molecular and Cellular Biology. 14(11). 7153–7162. 13 indexed citations
20.
Moodie, Shonna A., Mark Paris, Walter Kölch, & Alan Wolfman. (1994). Association of MEK1 with p21ras.GMPPNP is dependent on B-Raf.. Molecular and Cellular Biology. 14(11). 7153–7162. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James C. Geoghegan Breakdown of academic impact, for papers by E. Dreher Breakdown of academic impact, for papers by Saixia Ying Breakdown of academic impact, for papers by Tone Berge Breakdown of academic impact, for papers by Takehiko Koji Breakdown of academic impact, for papers by Sachiko Kubo Breakdown of academic impact, for papers by Jose G Ruiz de Morales Breakdown of academic impact, for papers by David Y. Chin Breakdown of academic impact, for papers by Karin Wagner Breakdown of academic impact, for papers by Jui‐Lan Su
Rankless by CCL
2026